Axovant IPO sparks talk of a biotech bubble By: MarketWatch June 12, 2015 at 14:38 PM EDT Axovant has just one drug candidate, a 29-year old CEO — and a market cap of nearly $3 billion. Read More >> Related Stocks: Biogen Idec Eli Lilly